Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Understanding Your LabsUnderstanding Your Labs
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


hi doc check this out and tell me your opinion
Dec 11, 2011

http://mr.caltech.edu/press_releases/13473

the above link is mouse research that if hold true also in humans, would mean a truly effective hiv vaccine and why not also a therapeutic aid for those already infected.

Response from Dr. Holodniy

Yes, this got a lot of buzz in the last couple of weeks. This approach (gene transfer therapy), using a harmless virus to deliver a gene into cells and having the cells start producing a protein or antibody, is being studied in multiple clinical trials in humans for all sorts of indications (cancers, blood disorders, etc, including HIV). This strategy was used to test the theory of a preventative vaccine in this study. There are ongoing studies in humans to look at this type of strategy in already HIV infected people.



Previous
CCR5 mutation and infection.
Next
VL down and CD4 down

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement